Under the Radar's issue this week focuses on a small cap biotech which could easily replicate the performance of Sirtex Medical, which has trebled subscribers' returns over the past year and a half.
Small Cap Biotech stock
Like Sirtex (SRX), this company’s produce is a medical device which has received clearance from the FDA, the giant US-based health regulator. It is one of only 100 companies to have achieved US Medicare reimbursement.
The numbers that this company can generate in terms of profits is absolutely astounding.
Dr Simon Marais from Allan Gray
Simon Marais manages over $4 billion and he is a big believer in Australia's capabilities in the biotech sector.
Subscribers can log in using their email and download the latest report to find out.